Quantitative measurement of acetyl fentanyl and acetyl norfentanyl in human urine by LC-MS/MS

Analytical Chemistry

Volumn 86, Issue 3, 2014, Pages 1760-1766

  Patton, Amy L ^a   Seely, Kathryn A ^a   Pulla, Sharon ^b   Rusch, Nancy J ^b   Moran, Cindy L ^c   Fantegrossi, William E ^b   Knight, Laura D ^d   Marraffa, Jeanna M ^e   Kennedy, Paul D ^f   James, Laura P ^g   Endres, Gregory W ^f   Moran, Jeffery H ^a,b  

^a ARKANSAS DEPARTMENT OF HEALTH   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c Arkansas State Crime Laboratory   (United States)

^d Onondaga County Medical Examiner's Office   (United States)

^e SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^f Cayman Chemical Company   (United States)

^g ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL PROCEDURE; CHROMATOGRAPHY COLUMNS; INTERNAL STANDARDS; LEVELS OF QUANTIFICATION; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (LC MS/MS); QUANTITATIVE MEASUREMENT; REFERENCE STANDARD; SOLID-PHASE EXTRACTION;

BODY FLUIDS; DETOXIFICATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM;

ANESTHETICS;

CYTOCHROME P450; DRUG DERIVATIVE; FENTANYL; NARCOTIC ANALGESIC AGENT; NORFENTANYL;

ANIMAL; ARTICLE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; METABOLISM; METHODOLOGY; RAT; TANDEM MASS SPECTROMETRY; URINALYSIS; URINE;

ANALGESICS, OPIOID; ANIMALS; CHROMATOGRAPHY, LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; FENTANYL; HUMANS; MALE; RATS; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 84893580502     PISSN: 00032700     EISSN: 15206882     Source Type: Journal    
DOI: 10.1021/ac4036197     Document Type: Article

References (15)

1. Johnston, L.; O'Malley, P.; Bachman, J.; Schulenberg, J. Monitoring the Future; University of Michigan News Service: Ann Arbor, MI, 2011, www.monitoringthefuture.org.
2. Watson, W. A.; Litovitz, T. L.; Rodgers, G. C., Jr.; Klein-Schwartz, W.; Reid, N.; Youniss, J.; Flanagan, A.; Wruk, K. M. Am. J. Emerg. Med. 2005, 23, 589-666
3. Manchikanti, L.; Singh, A. Pain Physician 2008, 11, S63-88
4. Okie, S. N. Engl. J. Med. 2010, 363, 1981-1985
5. CDC Morbidity and Mortality Weekly Report 2013, 62, 537-542
6. Perger, L.; Rentsch, K. M.; Kullak-Ublick, G. A.; Verotta, D.; Fattinger, K. Eur. J. Pharm. Sci. 2009, 36, 421-432
7. Reisinger, M. Heroin Addict. Relat. Clin. Probl. 2006, 8, 29-40
8. Kram, T. C.; Cooper, D. A.; Allen, A. C. Anal. Chem. 1981, 53, 1379A-1386A
9. CDC. CDC Health Alert Network, 2013, 00350.
10. CDC Morbidity and Mortality Weekly Report 2013, 62, 703-704
11. DEA, Office of Diversion Control-Drug & Chemical Evaluation Section. (2013.
12. Smith, H. S. Mayo Clin. Proc. 2009) 84, 613-624
13. Wolf, M. Pennsylvania Department of Health, 2013.
14. Labroo, R. B.; Paine, M. F.; Thummel, K. E.; Kharasch, E. D. Drug Metab. Dispos. 1997, 25, 1072-1080
15. Feierman, D. E.; Lasker, J. M. Drug Metab. Dispos. 1996, 24, 932-939